IMV Inc. to Present at Two Upcoming Investor Conferences
March 25 2019 - 7:05AM
Business Wire
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage
immuno-oncology company, today announced that IMV Chief Executive
Officer Frederic Ors will present at the Spring Investor Summit and
the HC Wainwright Global Life Sciences Conference during April
2019.
Details on each conference and presentation are as follows:
•
Venue: Spring Investor Summit,
being held April 1-2, 2019
•
Date of Presentation: Monday, April
1
•
Time: 8:30 a.m. ET
•
Location: JW Marriott Hotel, Essex
House, New York City
•
Venue: HC Wainwright Global Life
Sciences Conference, being held April 7-9, 2019
•
Date: Tuesday, April 9, 2019
•
Time: 10:40 a.m. BST
•
Location: Stratton Suite, Grosvenor
House, A JW Marriott Hotel, London, UK
There will be a live webcast of both of these presentations
available in the events, presentations and webcasts section of
IMV’s website. Following the presentations, the webcasts will be
archived for 90 days and a copy of the presentations will remain
available in the same section of the website.
About IMV
IMV Inc. is a clinical stage biopharmaceutical company dedicated
to making immunotherapy more effective, more broadly applicable,
and more widely available to people facing cancer and other serious
diseases. IMV is pioneering a new class of immunotherapies based on
the Company’s proprietary drug delivery platform. This patented
technology leverages a novel mechanism of action that enables the
programming of immune cells in vivo, which are aimed at
generating powerful new synthetic therapeutic capabilities. IMV’s
lead candidate, DPX-Survivac, is a T cell-activating immunotherapy
that combines the utility of the platform with a target: survivin.
IMV is currently assessing DPX-Survivac as a monotherapy in
advanced ovarian cancer, as well as a combination therapy in
multiple clinical studies with Merck. Connect
at www.imv-inc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190325005122/en/
Investor Relations:Marc Jasmin, IMV Senior Director,
Investor Relations and CommunicationsO: (902) 492-1819 ext : 1042M:
(514) 617-9481E: mjasmin@imv-inc.com
Media:Andrea Cohen, Sam Brown Inc.T: (917)
209-7163E: andreacohen@sambrown.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024